semaglutide elisa fda cleared ivd U.S. finds no evidence yet linking weight-loss drugs to suicidal thoughts Orbicular Receives US FDA Tentative

Most pregnant individuals are not meeting the adequate intake (AI) for choline (450 mg/day)

Autonomic regulation of islet hormone secretionimplications for health and disease

Smallwood MJ, Nissim A, Knight AR, Whiteman M, Haigh R, Winyard PG

Challenges Developing a robust LC-MS/MS method for semaglutide presented multiple challenges: Sensitivity requirements Detecting concentrations as low as 1 ng/mL required optimized sample preparation and chromatographic conditions

The approval was backed by data from the CARTITUDE-4 study, where treatment with Carvykti led to statistically significant and clinically meaningful improvement of progression-free survival compared to two standard of care treatment regimens, according to the companies

People with severe gastrointestinal disease, including gastroparesis, may not tolerate semaglutide well since it slows gastric emptying